Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Current Molecular Medicine|March 3, 2021
Potential Involvement of Extracellular Citrate in Brain Tumor ProgressionKatrin Jordan, Evan H Stanton, Vladimir M Milenkovic, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Molecular Cancer|January 20, 2009
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aTherese M Becker, Sebastian Haferkamp, Menno K Dijkstra, et al.
Frontiers in Immunology|October 17, 2022
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibitionGunther Glehr, Paloma Riquelme, Jordi Yang Zhou, et al.
Frontiers in Cell and Developmental Biology|July 18, 2024
Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues-correlation with tumour aggressivenessBarbara Schwertner, George Dahdal, Wolfgang Jagla, et al.
Cell|May 19, 2010
IGFBP7 is not required for B-RAF-induced melanocyte senescenceLyndee L Scurr, Gulietta M Pupo, Therese M Becker, et al.
Advances in Therapy|December 28, 2020
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European CountriesAlexander C J van Akkooi, Sebastian Haferkamp, Sophie Papa, et al.
Biomolecules|May 28, 2022
Immunometabolic Markers in a Small Patient Cohort Undergoing ImmunotherapyJoshua Hofbauer, Andreas Hauck, Carina Matos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective dataWiebke Sondermann, Jochen Sven Utikal, Alexander H Enk, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Current Molecular Medicine|March 3, 2021
Potential Involvement of Extracellular Citrate in Brain Tumor ProgressionKatrin Jordan, Evan H Stanton, Vladimir M Milenkovic, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Molecular Cancer|January 20, 2009
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aTherese M Becker, Sebastian Haferkamp, Menno K Dijkstra, et al.
Frontiers in Immunology|October 17, 2022
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibitionGunther Glehr, Paloma Riquelme, Jordi Yang Zhou, et al.
Frontiers in Cell and Developmental Biology|July 18, 2024
Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues-correlation with tumour aggressivenessBarbara Schwertner, George Dahdal, Wolfgang Jagla, et al.
Cell|May 19, 2010
IGFBP7 is not required for B-RAF-induced melanocyte senescenceLyndee L Scurr, Gulietta M Pupo, Therese M Becker, et al.
Advances in Therapy|December 28, 2020
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European CountriesAlexander C J van Akkooi, Sebastian Haferkamp, Sophie Papa, et al.
Biomolecules|May 28, 2022
Immunometabolic Markers in a Small Patient Cohort Undergoing ImmunotherapyJoshua Hofbauer, Andreas Hauck, Carina Matos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective dataWiebke Sondermann, Jochen Sven Utikal, Alexander H Enk, et al.
Pageof 15